Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang No.1 Pharmaceutical is a major Chinese pharmaceutical manufacturer and a key subsidiary of the Northeast Pharmaceutical Group (NEPG). Founded in 1946 as the Shenyang No.1 Pharmaceutical Factory, the company has evolved into a large-scale production hub for essential medicines, including antibiotics, vitamins, and cardiovascular drugs. It is recognized as one of the world's largest producers of Vitamin C and its derivatives, maintaining significant export operations to global markets. The company's facilities are GMP-certified, supporting the manufacture of both active pharmaceutical ingredients (APIs) and finished dosage forms. As a core component of NEPG, it plays a vital role in China's domestic drug supply and international pharmaceutical trade.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang No.1 Pharmaceutical.